These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16197719)

  • 1. Biology of osteogenic sarcoma.
    Wang LL
    Cancer J; 2005; 11(4):294-305. PubMed ID: 16197719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteosarcoma development and stem cell differentiation.
    Tang N; Song WX; Luo J; Haydon RC; He TC
    Clin Orthop Relat Res; 2008 Sep; 466(9):2114-30. PubMed ID: 18563507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ezrin in osteosarcoma metastasis.
    Ren L; Khanna C
    Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Singe nucleotide polymorphisms in osteosarcoma: Pathogenic effect and prognostic significance.
    Asnafi AA; Behzad MM; Ghanavat M; Shahjahani M; Saki N
    Exp Mol Pathol; 2019 Feb; 106():63-77. PubMed ID: 30528563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
    Gorlick R; Anderson P; Andrulis I; Arndt C; Beardsley GP; Bernstein M; Bridge J; Cheung NK; Dome JS; Ebb D; Gardner T; Gebhardt M; Grier H; Hansen M; Healey J; Helman L; Hock J; Houghton J; Houghton P; Huvos A; Khanna C; Kieran M; Kleinerman E; Ladanyi M; Lau C; Malkin D; Marina N; Meltzer P; Meyers P; Schofield D; Schwartz C; Smith MA; Toretsky J; Tsokos M; Wexler L; Wigginton J; Withrow S; Schoenfeldt M; Anderson B
    Clin Cancer Res; 2003 Nov; 9(15):5442-53. PubMed ID: 14654523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of osteosarcoma.
    Kansara M; Thomas DM
    DNA Cell Biol; 2007 Jan; 26(1):1-18. PubMed ID: 17263592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma.
    Benassi MS; Molendini L; Gamberi G; Magagnoli G; Ragazzini P; Gobbi GA; Sangiorgi L; Pazzaglia L; Asp J; Brantsing C; Picci P
    Cancer; 2001 Dec; 92(12):3062-7. PubMed ID: 11753985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Malignant Bone Tumors: A Review and Update on Current Challenges, and Emerging Drug Targets.
    Jackson TM; Bittman M; Granowetter L
    Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):213-228. PubMed ID: 27265835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
    Fenger JM; London CA; Kisseberth WC
    ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress on the livin gene and osteosarcomas.
    Li CJ; Cong Y; Liu XZ; Zhou X; Shi X; Wu SJ; Zhou GX; Lu M
    Asian Pac J Cancer Prev; 2014; 15(20):8577-9. PubMed ID: 25374170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RECQ DNA helicases and osteosarcoma.
    Lu L; Jin W; Liu H; Wang LL
    Adv Exp Med Biol; 2014; 804():129-45. PubMed ID: 24924172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
    Lamoureux F; Trichet V; Chipoy C; Blanchard F; Gouin F; Redini F
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):169-81. PubMed ID: 17288528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
    Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response.
    Trujillo-Paolillo A; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia Filho RJ; de Oliveira R; de Toledo SRC
    Oncotarget; 2017 Jun; 8(24):38530-38540. PubMed ID: 28404946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
    Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
    Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions.
    Lussier DM; O'Neill L; Nieves LM; McAfee MS; Holechek SA; Collins AW; Dickman P; Jacobsen J; Hingorani P; Blattman JN
    J Immunother; 2015 Apr; 38(3):96-106. PubMed ID: 25751499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
    Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
    Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis of genetic transmission in a father and son with osteosarcoma].
    Tokatli F; Alas RC; Altaner S; Pala F; Uygun K; Uzal C; Yalniz E
    Acta Orthop Traumatol Turc; 2006; 40(5):407-10. PubMed ID: 17220652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiation potencies and clinical aspects of primary osteogenic sarcomas].
    Wittig G; Wildner GP
    Arch Geschwulstforsch; 1967; 30(1):53-70. PubMed ID: 4298758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.